GeneDx Holdings (WGS) Gross Margin (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Gross Margin of 66.71% for Q1 2026, down 42.0% year-over-year from 115.01% in Q1 2025, and down 4.22% quarter-over-quarter from 69.65% in Q4 2025.
GeneDx Holdings (WGS) Gross Margin (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Gross Margin for 7 consecutive years, with 66.71% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 42.0% year-over-year to 66.71%; the TTM figure through Mar 2026 stood at 69.56% (up 429.0% YoY), while the FY2025 annual figure was 69.74%, up 610.0% from the prior year.
- Gross Margin slipped to 66.71% in Q1 2026 per WGS's latest filing, from 69.65% in the prior quarter.
- Across five years, Gross Margin topped out at 72.4% in Q3 2025 and bottomed at 81.83% in Q2 2022.
- Historically, Gross Margin has averaged 40.6% across 5 years, with a median of 59.93% in 2024.
- Annual changes were most pronounced in 2022 — Gross Margin tumbled 7936 bps — and 2023, when it jumped 12034 bps.
- GeneDx Holdings' Gross Margin stood at 26.61% in 2022, then soared by 301 bps to 53.56% in 2023, then advanced by 29 bps to 69.22% in 2024, then advanced by 1 bps to 69.65% in 2025, then decreased by 4 bps to 66.71% in 2026.
- Business Quant data shows WGS's Gross Margin at 66.71% in Q1 2026, 69.65% in Q4 2025, and 72.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 68.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.37% |
| Mar 31, 2026 | 66.71% |
| Dec 31, 2025 | 69.65% |
| Sep 30, 2025 | 72.40% |
| Jun 30, 2025 | 69.04% |
| Mar 31, 2025 | 67.13% |
| Dec 31, 2024 | 69.22% |
| Sep 30, 2024 | 62.22% |
| Jun 30, 2024 | 60.91% |
| Mar 31, 2024 | 59.93% |
| Dec 31, 2023 | 53.56% |
| Sep 30, 2023 | 47.39% |
| Jun 30, 2023 | 38.51% |
| Mar 31, 2023 | 35.32% |
| Dec 31, 2022 | -26.61% |
| Sep 30, 2022 | 16.28% |
| Jun 30, 2022 | -81.83% |
| Mar 31, 2022 | 10.43% |
| Dec 31, 2021 | -4.85% |
| Sep 30, 2021 | -19.24% |